JP2003260340A - Hydrophilic polysulfone membrane - Google Patents

Hydrophilic polysulfone membrane

Info

Publication number
JP2003260340A
JP2003260340A JP2002068050A JP2002068050A JP2003260340A JP 2003260340 A JP2003260340 A JP 2003260340A JP 2002068050 A JP2002068050 A JP 2002068050A JP 2002068050 A JP2002068050 A JP 2002068050A JP 2003260340 A JP2003260340 A JP 2003260340A
Authority
JP
Japan
Prior art keywords
polysulfone
hydrophilic
aco
membrane
acc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002068050A
Other languages
Japanese (ja)
Other versions
JP4296746B2 (en
Inventor
Akihiko Ito
明彦 伊藤
Hiroyuki Sugaya
博之 菅谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2002068050A priority Critical patent/JP4296746B2/en
Publication of JP2003260340A publication Critical patent/JP2003260340A/en
Application granted granted Critical
Publication of JP4296746B2 publication Critical patent/JP4296746B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a polysulfone membrane with suppressed adsorption of proteins as a membrane for separation or concentration of antigens, enzymes or the like or for hemocatharsis by dialysis of blood or filtration of blood. <P>SOLUTION: The membrane comprises a polysulfone resin containing a hydrophilic polymer or a polymer having a hydrophilic segment. In the IR absorption spectra of the membrane measured at 100 points with a 20×20 μm angle of view, the number of measuring points satisfying an inequality of (Aco)/(Acc)≤0.15 is ≤5, wherein Aco is the intensity of the absorption peak indicating C=O near 1660 cm<SP>-1</SP>and Acc is the intensity of the absorption peak indicating the benzene ring C=C in the polysulfone near 1580 cm<SP>-1</SP>. The average μof the ratio (Aco)/(Acc) is ≥0.1 and <0.4. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、タンパク吸着の抑
制されたポリスルホン系膜に関するものであり、抗体、
酵素などの分離、濃縮や血液透析、血液フィルターなど
の血液浄化用に有用である。
TECHNICAL FIELD The present invention relates to a polysulfone-based membrane in which protein adsorption is suppressed, which comprises an antibody,
It is useful for separating and concentrating enzymes and blood purification such as hemodialysis and blood filters.

【0002】[0002]

【従来の技術】ポリスルホン系ポリマーは耐放射線性お
よび耐熱性に優れているが、ポリスルホン自体は疎水性
であり、血液中の血小板や血球など、タンパクが吸着し
やすいという欠点を有している。そのため、抗体、酵素
などの分離、濃縮や血液透析、血液フィルターなど、血
液浄化用として使用されるときは、血液適合性を付与す
るためにポリビニルピロリドンなどの親水性高分子をブ
レンドして用いられている。
2. Description of the Related Art Polysulfone polymers are excellent in radiation resistance and heat resistance, but polysulfone itself is hydrophobic and has a drawback that proteins such as platelets and blood cells in blood are easily adsorbed. Therefore, when used for blood purification such as separation and concentration of antibodies and enzymes, hemodialysis, blood filters, etc., it is used by blending hydrophilic polymers such as polyvinylpyrrolidone to impart blood compatibility. ing.

【0003】親水性高分子のブレンドが、タンパクの吸
着抑制に効果的である理由には、様々な説が考えられて
いるが、たとえば、血液との接触表面における親水性向
上により、タンパクとの疎水性相互作用が抑制されるた
め、また、接触表面からつきだした親水性高分子鎖のワ
イパー効果が発現する、あるいは、親水性高分子上にで
きると考えられている水の層構造が、タンパク吸着のき
っかけである、不凍水とタンパクの水和水との接触を阻
害することなどがある。しかしながら、このような親水
性高分子の含有量が不十分であったり、ブレンドされた
親水性高分子のポリスルホン系ポリマー中での分散状態
が不均一であったりすると、局部的に疎水性の高い部分
が生じ、その部分がタンパクの吸着を起こしやすくする
と考えられる。
Various theories have been considered as to the reason why the blend of hydrophilic polymers is effective in suppressing the adsorption of proteins. For example, by improving the hydrophilicity of the contact surface with blood, Since the hydrophobic interaction is suppressed, the wiper effect of the hydrophilic polymer chain protruding from the contact surface is expressed, or the water layer structure which is considered to be formed on the hydrophilic polymer is It may interfere with the contact between antifreeze water and protein hydration water, which is a trigger for protein adsorption. However, if the content of such hydrophilic polymer is insufficient or if the blended hydrophilic polymer is unevenly dispersed in the polysulfone-based polymer, locally high hydrophobicity is obtained. It is considered that a part is generated, and that part easily causes protein adsorption.

【0004】また、ブレンドされているポリビニルピロ
リドンは、放射線照射により架橋し、不溶化する。不溶
化することで、血液接触時にポリビニルピロリドンの血
液への溶出を低減することができると考えられている
が、ポリビニルピロリドンが架橋しすぎると、血液が膜
表面に接触した際に血小板が活性化することが知られて
いる(特開平9−323031公報)。この理由につい
てはまだ、はっきりしたことはわかっていないが、放射
線照射によるポリビニルピロリドン高分子鎖の分解およ
び架橋により、分子鎖の可動性が低下し、ワイパー効果
が低減するため、あるいはポリビニルピロリドンの架橋
により、もともとポリスルホンの少ない部分のポリスル
ホン表面が露わになって、そこに血小板が吸着すること
などが考えられる。
The blended polyvinylpyrrolidone is crosslinked and insolubilized by irradiation with radiation. It is believed that the insolubilization can reduce the elution of polyvinylpyrrolidone into blood upon contact with blood, but if polyvinylpyrrolidone crosslinks too much, platelets will be activated when blood contacts the membrane surface. It is known (Japanese Patent Laid-Open No. 9-323031). The reason for this is not yet clear, but the degradation and cross-linking of the polyvinylpyrrolidone polymer chain by irradiation reduces the mobility of the molecular chain and reduces the wiper effect. It is conceivable that the surface of the polysulfone originally having a small amount of polysulfone is exposed, and platelets are adsorbed there.

【0005】タンパク吸着が抑制されたポリスルホン系
膜としては、膜表面の収着水構造とタンパク吸着の関係
に着目し、赤外吸収スペクトル測定を行って、タンパク
吸着の抑制された膜を特徴付ける試みがされているが、
タンパク吸着はミクロな現象であり、同じ親水性表面と
いっても、よりミクロな視点で見ると親水性部位の分散
状態が異なる場合もあり、前記赤外吸収スペクトル測定
では、そこまでの膜特性を規定するものではなかった
(特開平9−122462公報)。
As a polysulfone-based membrane in which protein adsorption is suppressed, attention is paid to the relationship between the sorbed water structure on the membrane surface and protein adsorption, and an infrared absorption spectrum measurement is performed to attempt to characterize the membrane in which protein adsorption is suppressed. Has been
Protein adsorption is a microscopic phenomenon, and even with the same hydrophilic surface, the dispersion state of hydrophilic parts may differ from a more microscopic viewpoint. Was not specified (JP-A-9-122462).

【0006】[0006]

【発明が解決しようとする課題】本発明の目的は、前記
のような欠点を克服し、タンパク吸着が抑制されたポリ
スルホン系膜を提供することである。
SUMMARY OF THE INVENTION An object of the present invention is to provide a polysulfone-based membrane that overcomes the above-mentioned drawbacks and that suppresses protein adsorption.

【0007】[0007]

【課題を解決するための手段】上記課題を解決するた
め、本発明は以下の構成を有する。すなわち、 (1)親水性ポリマーまたは親水性セグメントを含むポ
リマーを含むポリスルホン系樹脂からなる膜であり、赤
外吸収スペクトルにおいて20×20μmの視野角で1
00点測定したとき、1660cm-1付近のC=O由来の吸
収ピークの強度(Aco)と、1580cm-1付近のポリス
ルホンのベンゼン環C=C由来の吸収ピークの強度(Ac
c)の比(Aco)/(Acc)が0.15以下である測定
点の数が5以下であり、比(Aco)/(Acc)の平均値
μが0.1以上0.4未満であることを特徴とする親水
性ポリスルホン系膜。
In order to solve the above problems, the present invention has the following constitution. That is, (1) a film made of a polysulfone resin containing a hydrophilic polymer or a polymer containing a hydrophilic segment, and having a viewing angle of 20 × 20 μm in an infrared absorption spectrum
When measured at 00 points, the intensity of the absorption peak derived from C = O near 1660 cm -1 (Aco) and the intensity of the absorption peak derived from benzene ring C = C of polysulfone near 1580 cm -1 (Ac
The ratio (Aco) / (Acc) of c) is 0.15 or less, the number of measurement points is 5 or less, and the average value μ of the ratio (Aco) / (Acc) is 0.1 or more and less than 0.4. A hydrophilic polysulfone-based membrane characterized by being present.

【0008】(2)親水性ポリマーがポリビニルピロリ
ドンであることを特徴とする(1)記載の親水性ポリス
ルホン系膜。
(2) The hydrophilic polysulfone-based membrane as described in (1), wherein the hydrophilic polymer is polyvinylpyrrolidone.

【0009】(3)親水性セグメントがポリビニルピロ
リドンであることを特徴とする(1)記載の親水性ポリ
スルホン系膜。
(3) The hydrophilic polysulfone-based membrane according to (1), wherein the hydrophilic segment is polyvinylpyrrolidone.

【0010】[0010]

【発明の実施の形態】本発明の分離膜の形態は特に限定
されるものではなく、平膜、中空糸膜などの形態で用い
られる。しかし、人工腎臓機能を兼ねたり、処理効率す
なわち血液と接触する表面積の確保などを考慮すると中
空糸膜型であることが好ましい。
BEST MODE FOR CARRYING OUT THE INVENTION The form of the separation membrane of the present invention is not particularly limited, and may be a flat membrane, a hollow fiber membrane or the like. However, the hollow fiber membrane type is preferable in view of the function of the artificial kidney and the treatment efficiency, that is, the securing of the surface area in contact with blood.

【0011】高分子溶質がタンパク質であり、ポリマー
が疎水性の強いものである場合には、多量のタンパク質
の吸着が観測される。このため、ポリマー表面を親水性
に加工することによって、ある程度の吸着の抑制は可能
であるが、このような親水化がポリマー表面に十分な密
度で均一に行われていなくて、疎水性の強い部分が残っ
ているとその部分にタンパクの吸着が起こると考えられ
る。
When the polymer solute is a protein and the polymer is highly hydrophobic, adsorption of a large amount of protein is observed. For this reason, it is possible to suppress adsorption to some extent by processing the polymer surface to be hydrophilic, but such hydrophilicization is not uniformly performed at a sufficient density on the polymer surface, and the hydrophobicity is strong. If a portion remains, it is considered that protein adsorption occurs in that portion.

【0012】そこで親水性ポリマー、特にC=O基を持つ
親水性ポリマーまたは、C=O基を持つ親水性セグメント
を含むポリマーを含むポリスルホン系樹脂における、親
水性セグメントの含有量およびその平面的な分散状態を
解析する上で赤外吸収スペクトルを用い、タンパク吸着
との相関について研究を行った結果、親水性ポリマーま
たは親水性セグメントを含むポリマーを含むポリスルホ
ン系樹脂からなる膜であり、赤外吸収スペクトルにおい
て20×20μmの視野角で100点測定したとき、1
660cm-1付近のC=O由来の吸収ピークの強度(Aco)
と、1580cm-1付近のポリスルホンのベンゼン環C=C
由来の吸収ピークの強度(Acc)の比(Aco)/(Ac
c)が0.15以下である測定点の数が5以下であり、
比(Aco)/(Acc)の平均値μが0.1以上0.4未
満である親水性ポリスルホン系膜が特にタンパク質など
の吸着が少なく、抗体、酵素などの分離、濃縮や血液透
析、血液フィルターなどの血液浄化用に有用であること
を見出した。
Therefore, the content of the hydrophilic segment in the polysulfone resin containing the hydrophilic polymer, particularly the hydrophilic polymer having a C═O group or the polymer containing the hydrophilic segment having a C═O group and its planar As a result of investigating the correlation with protein adsorption using the infrared absorption spectrum in analyzing the dispersion state, it was found that the film was composed of a polysulfone resin containing a hydrophilic polymer or a polymer containing a hydrophilic segment. 1 when measured at 100 points with a 20 × 20 μm viewing angle in the spectrum
Intensity of absorption peak derived from C = O near 660 cm -1 (Aco)
And the benzene ring C = C of polysulfone near 1580 cm -1
Ratio (Aco) / (Ac of intensity (Acc) of absorption peak derived from
The number of measurement points where c) is 0.15 or less is 5 or less,
The hydrophilic polysulfone-based membrane having an average value μ of the ratio (Aco) / (Acc) of 0.1 or more and less than 0.4 has particularly low adsorption of proteins and the like, separation of antibodies and enzymes, concentration and hemodialysis, blood It was found to be useful for blood purification such as filters.

【0013】本発明におけるポリスルホン系樹脂として
は、ポリスルホン、ポリエーテルスルホンなどが挙げら
れる。
Examples of the polysulfone resin in the present invention include polysulfone and polyether sulfone.

【0014】本発明における親水性ポリマーとしては、
分子中にC=O基を含む水溶性ポリマーであればよいが、
例えばポリビニルピロリドン、ポリアクリル酸、ポリメ
タクリル酸等を挙げることができ、好ましくはポリビニ
ルピロリドンである。また、親水性セグメントを含むポ
リマーとしては、主鎖がC=O基を含む親水性セグメント
と疎水性セグメントからなるブロックコポリマー、高分
子鎖の幹がC=O基を含む親水性ポリマー、例えばポリビ
ニルピロリドン、枝が疎水性セグメントからなる、ある
いは逆に幹が疎水性で、枝がC=O基を含む親水性ポリマ
ー、例えばポリビニルピロリドンからなるグラフトコポ
リマーなどを挙げることができる。好ましい疎水性セグ
メントとしては、ポリスチレンセグメントやポリメチル
(メタ)アクリレート、ポリブチル(メタ)アクリレー
ト等の疎水性(メタ)アクリレート系ポリマーセグメン
トを挙げることができ、さらに好ましくはポリスチレン
セグメントを挙げることができる。
The hydrophilic polymer in the present invention includes
Any water-soluble polymer containing a C = O group in the molecule may be used,
Examples thereof include polyvinylpyrrolidone, polyacrylic acid, polymethacrylic acid, and the like, with polyvinylpyrrolidone being preferred. Further, as the polymer containing a hydrophilic segment, the main chain is a block copolymer consisting of a hydrophilic segment containing a C = O group and a hydrophobic segment, the hydrophilic polymer containing a C = O group in the backbone of the polymer chain, such as polyvinyl. Pyrrolidone, a hydrophilic polymer having branches having hydrophobic segments, or conversely, having a hydrophobic trunk and having C═O groups, such as a graft copolymer made of polyvinylpyrrolidone can be mentioned. Examples of preferable hydrophobic segments include polystyrene segments and hydrophobic (meth) acrylate polymer segments such as polymethyl (meth) acrylate and polybutyl (meth) acrylate, and more preferably polystyrene segments.

【0015】上記親水性ポリマー、または親水性セグメ
ントを含むポリマーの分子量としては、3万ダルトンか
ら200万ダルトンの範囲にあることが好ましく、より
好ましくは5万ダルトンから150万ダルトンである。
分子量が小さすぎると膜からの溶出が多くなり、使用上
好ましくなく、分子量が大きすぎると、ポリスルホン樹
脂との混合性が悪くなり、分散性が悪くなることがあ
る。
The molecular weight of the hydrophilic polymer or the polymer containing a hydrophilic segment is preferably in the range of 30,000 daltons to 2 million daltons, more preferably 50,000 daltons to 1.5 million daltons.
If the molecular weight is too small, elution from the membrane increases, which is not preferable for use. If the molecular weight is too large, the miscibility with the polysulfone resin may deteriorate and the dispersibility may deteriorate.

【0016】本発明における最も重要な点は、親水性ポ
リマー、親水性セグメントを含むポリマーのポリスルホ
ン樹脂における含有量、および分散性にある。まず、赤
外吸収スペクトルにおいて20×20μmの視野角で1
00点測定したとき、1660cm-1付近のC=O由来の吸
収ピークの強度(Aco)と、1580cm-1付近のポリス
ルホンのベンゼン環C=C由来の吸収ピークの強度(Ac
c)の比(Aco)/(Acc)が0.15以下である測定
点の数が5以下であることが必要であり、5を超える場
合は、親水性が弱い部分が多く、その部分にタンパクが
付着しやすくなる。本発明の前記吸収ピーク強度比(A
co)/(Acc)は膜の親水性を表す指標であり、一般的
に値が大きいほど親水性が高く、タンパク吸着が抑制さ
れると考えられるが、大きすぎると膜からの溶出が多く
なるという欠点がある。したがって、前記比(Aco)/
(Acc)の平均値μが0.1以上0.4未満であること
が必要であり、0.1未満の場合にはポリスルホン系樹
脂の親水性が十分でなく、0.4を超える場合はポリス
ルホン樹脂からの親水性ポリマー、親水性セグメントを
含むポリマーの溶出が多くなり、実用上好ましくない。
具体的に本発明の膜の測定は、同じ膜から、10個の測
定サンプルを調製し、1個のサンプルから10点、合計
100点行う。それぞれ1個のサンプル内での測定は、
前記 20×20μmの正方形の視野角が縦に2個横に5
個隙間無く並ぶ形で、互いの視野角が重ならないよう
に、しかも互いの視野角が隙間無く接触するように、走
査して行う。尚、本発明における赤外吸収スペクトルの
吸収ピークの強度は実施例中に記載の方法で求められ
る。
The most important points in the present invention are the hydrophilic polymer, the content of the polymer containing the hydrophilic segment in the polysulfone resin, and the dispersibility. First, in the infrared absorption spectrum, 1 at a viewing angle of 20 × 20 μm
When measured at 00 points, the intensity of the absorption peak derived from C = O near 1660 cm -1 (Aco) and the intensity of the absorption peak derived from benzene ring C = C of polysulfone near 1580 cm -1 (Ac
The ratio (Aco) / (Acc) of c) is 0.15 or less, and the number of measurement points must be 5 or less. When it exceeds 5, there are many weakly hydrophilic portions and Protein will be easily attached. The absorption peak intensity ratio (A
co) / (Acc) is an index showing the hydrophilicity of the membrane. Generally, the larger the value is, the higher the hydrophilicity is, and it is considered that protein adsorption is suppressed, but if it is too large, the elution from the membrane increases. There is a drawback that. Therefore, the ratio (Aco) /
It is necessary that the average value μ of (Acc) is 0.1 or more and less than 0.4. If it is less than 0.1, the hydrophilicity of the polysulfone resin is not sufficient, and if it exceeds 0.4, Elution of the hydrophilic polymer and the polymer containing the hydrophilic segment from the polysulfone resin increases, which is not preferable in practice.
Specifically, the measurement of the film of the present invention is performed by preparing 10 measurement samples from the same film, and performing 10 points from one sample, for a total of 100 points. Each measurement within one sample is
The 20 × 20 μm square has two viewing angles of 5 vertically.
Scanning is performed so that the viewing angles do not overlap with each other and the viewing angles are in contact with each other without a gap in a form in which the viewing angles do not overlap. The intensity of the absorption peak of the infrared absorption spectrum in the present invention is determined by the method described in the examples.

【0017】上記の条件を満たす膜は、乾湿式法によっ
て紡糸し、グリセリンを含む水溶液中でγ線を照射する
ことによって得ることができる。さらに親水性ポリマ
ー、親水性セグメントを含むポリマーの組成、製膜条
件、後処理条件を調整することにより、親水性ポリマ
ー、親水性セグメントを含むポリマーがポリスルホン系
樹脂に適切に配合された膜を得ることができる。
The membrane satisfying the above conditions can be obtained by spinning by a dry-wet method and irradiating with γ-ray in an aqueous solution containing glycerin. Furthermore, by adjusting the composition of the hydrophilic polymer and the polymer containing the hydrophilic segment, the film-forming conditions, and the post-treatment conditions, a film in which the hydrophilic polymer and the polymer containing the hydrophilic segment are properly blended with the polysulfone-based resin is obtained. be able to.

【0018】[0018]

【実施例】次に実施例により本発明を更に詳細に説明す
るが、本発明はこれらの例によってなんら限定されるも
のではない。まず、本実施例において用いられる評価法
について記載する。
The present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. First, the evaluation method used in this example will be described.

【0019】(1)赤外吸収スペクトル測定サンプルの
調整 測定サンプルはあらかじめ、水等に最低1時間浸漬し
て、よく洗浄しておく必要があり、中空糸の場合には、
管軸を通る平面で膜を切断してから洗浄する。サンプル
は平膜であれば、約5mm角の大きさの正方形を10個を
お互いにできるだけ離れた場所でサンプリングしたも
の、中空糸であれば、10本の糸から各々、上記のよう
に管軸を通る平面で切断したものを用意する。
(1) Preparation of infrared absorption spectrum measurement sample It is necessary to immerse the measurement sample in water or the like for at least 1 hour in advance and thoroughly wash it. In the case of hollow fibers,
The membrane is cut in a plane passing through the tube axis and then washed. If the sample is a flat membrane, then 10 squares of about 5 mm square are sampled at locations as far apart from each other as possible, and if it is a hollow fiber, each of 10 threads is sampled as described above. Prepare the one cut along the plane passing through.

【0020】(2)赤外吸収スペクトル測定 測定は顕微赤外吸収スペクトル測定装置を用い、反射モ
ードで、赤外光のあたる範囲である視野角を20μ×2
0μmに設定する。1個のサンプルにつき10点を各々
のサンプルで測定するため、合計100点測定すること
になる。1個のサンプル内の測定方法は、まず、上記視
野角を各々の測定範囲が重ならないようにスキャンし、
全体で縦5点×横2点、縦2点×横5点すなわち、10
0μ×40μmの範囲を見ることとする。測定条件は分
解能4、積算回数64回とする。
(2) Infrared absorption spectrum measurement A microscopic infrared absorption spectrum measurement device was used for measurement, and the viewing angle, which is the range of infrared light, was 20 μ × 2 in reflection mode.
Set to 0 μm. Since 10 points are measured for each sample, a total of 100 points will be measured. The measuring method in one sample is as follows. First, scan the viewing angles so that the respective measurement ranges do not overlap,
5 points vertically x 2 points horizontally, 2 points vertically x 5 points horizontally, or 10
Let us see the range of 0 μ × 40 μm. The measurement conditions are a resolution of 4 and an integration count of 64 times.

【0021】(3)赤外吸収スペクトル強度 得られた赤外吸収スペクトルのベースライン補正を行
う。補正は1700cm-1および1000cm-1の点を吸収
強度0にすることとする。1660cm-1付近のC=O由来
の吸収ピークの強度(Aco)と、1580cm-1付近のポ
リスルホンのベンゼン環C=C由来の吸収ピークの強度
(Acc)を求め、その比(Aco)/(Acc)を計算し、
比が0.15以下の測定点の数と100個の測定点の平
均値(μ)を求める。
(3) Infrared absorption spectrum intensity Baseline correction of the obtained infrared absorption spectrum is performed. The correction is to make the absorption intensity 0 at the points of 1700 cm -1 and 1000 cm -1 . The intensity of the absorption peak derived from C = O near 1660 cm -1 (Aco) and the intensity of the absorption peak derived from the benzene ring C = C of polysulfone near 1580 cm -1 (Acc) were determined, and the ratio (Aco) / ( Acc),
The number of measurement points having a ratio of 0.15 or less and the average value (μ) of 100 measurement points are obtained.

【0022】(4)血小板付着量評価 各々のサンプルの血小板付着量は、サンプルが中空糸の
場合で評価した。被測定中空糸膜を長さ12cmに切
り、30本束ねて小型モジュール化を行い、クエン酸添
加家兎新鮮血を0.59ml/minにて60分間通過灌流さ
せ、続いて生理食塩水を1分間通過させた。次に、中空
糸100cmを細断し、0.5%トリトンX−100を
含む生理食塩水中で超音波照射して、膜表面に粘着した
血小板から放出される乳酸脱水素酵素を定量した。酵素
活性の測定は、モノテストLDH(ロッシュ)を使用し
た。この際、灌流血として、ウサギ血を用いた。
(4) Evaluation of Platelet Adhesion Amount of platelet adhesion of each sample was evaluated when the sample was a hollow fiber. Cut the hollow fiber membrane to be measured to 12 cm in length, bundle 30 pieces into a small module, and perfuse fresh citric acid-added rabbit blood for 60 minutes at 0.59 ml / min, followed by 1 saline solution. Passed for a minute. Next, 100 cm of the hollow fiber was chopped and ultrasonically irradiated in physiological saline containing 0.5% Triton X-100 to quantify the lactate dehydrogenase released from the platelets adhered to the membrane surface. For the measurement of enzyme activity, Monotest LDH (Roche) was used. At this time, rabbit blood was used as perfusion blood.

【0023】実施例1 ポリスルホン(テイジンアモコ社製ユーデルP−350
0)18部、ポリビニルピロリドン(BASF社製K3
0)9部をN,N−ジメチルアセトアミド72部、水1
部に加え、90℃14時間加熱溶解した。この製膜原液
を外径0.3mm、内径0.2mmのオリフィス型二重
円筒型口金より吐出し芯液としてジメチルアセトアミド
58部、水42部からなる溶液を吐出させ、乾式長35
0mmを通過した後、水100%の凝固浴に導き中空糸
を得た。得られた中空糸膜をグリセリン0.5%、ポリ
ビニルピロリドン(BASF社製K90)0.1%を含
む水溶液中でγ線照射した。γ線照射線量は25kGy
であった。この中空糸10本を各々管軸を通る平面で切
断して、水に1時間以上浸漬した後に、赤外吸収スペク
トルを測定したところ、比(Aco)/(Acc)が0.1
5以下である測定点の数は0で、比(Aco)/(Acc)
の平均値μの値は0.33であった。血小板付着量を評
価した結果、3.0unit/cmであった。
Example 1 Polysulfone (Tedel Amoco Udel P-350)
0) 18 parts, polyvinylpyrrolidone (K3 manufactured by BASF)
0) 9 parts of N, N-dimethylacetamide 72 parts, water 1
In addition to the parts, the mixture was heated and dissolved at 90 ° C. for 14 hours. This film-forming stock solution was discharged from an orifice type double cylindrical die having an outer diameter of 0.3 mm and an inner diameter of 0.2 mm to discharge a solution consisting of 58 parts of dimethylacetamide and 42 parts of water as a core liquid, and a dry length of 35
After passing 0 mm, it was introduced into a coagulation bath of 100% water to obtain a hollow fiber. The obtained hollow fiber membrane was irradiated with γ-rays in an aqueous solution containing 0.5% of glycerin and 0.1% of polyvinylpyrrolidone (K90 manufactured by BASF). γ-ray irradiation dose is 25 kGy
Met. Ten hollow fibers were each cut along a plane passing through the tube axis and immersed in water for 1 hour or more, and then the infrared absorption spectrum was measured. The ratio (Aco) / (Acc) was 0.1.
The number of measurement points that are 5 or less is 0, and the ratio (Aco) / (Acc)
The average value μ of was 0.33. As a result of evaluating the amount of adhered platelets, it was 3.0 unit / cm.

【0024】実施例2 ポリスルホン(テイジンアモコ社製ユーデルP−350
0)18部、ポリビニルピロリドン(BASF社製K3
0)9部をN,N−ジメチルアセトアミド72部、水1
部に加え、90℃14時間加熱溶解した。この製膜原液
を外径0.3mm、内径0.2mmのオリフィス型二重
円筒型口金より吐出し芯液としてジメチルアセトアミド
58部、水42部からなる溶液を吐出させ、乾式長35
0mmを通過した後、水100%の凝固浴に導き中空糸
を得た。得られた中空糸膜をグリセリン0.1%を含む
水溶液中でγ線照射した。γ線吸収線量は25kGyで
あった。この中空糸10本を各々管軸を通る平面で切断
して、水に1時間以上浸漬した後に、赤外吸収スペクト
ルを測定したところ、比(Aco)/(Acc)が0.15
以下である測定点の数は0で、比(Aco)/(Acc)の
平均値μの値は0.32であった。血小板付着量を評価
した結果、7.2unit/cmであった。
Example 2 Polysulfone (Tedel Amoco Udel P-350)
0) 18 parts, polyvinylpyrrolidone (K3 manufactured by BASF)
0) 9 parts of N, N-dimethylacetamide 72 parts, water 1
In addition to the parts, the mixture was heated and dissolved at 90 ° C. for 14 hours. This film-forming stock solution was discharged from an orifice type double cylindrical die having an outer diameter of 0.3 mm and an inner diameter of 0.2 mm to discharge a solution consisting of 58 parts of dimethylacetamide and 42 parts of water as a core liquid, and a dry length of 35
After passing 0 mm, it was introduced into a coagulation bath of 100% water to obtain a hollow fiber. The obtained hollow fiber membrane was irradiated with γ-ray in an aqueous solution containing 0.1% of glycerin. The absorbed dose of γ rays was 25 kGy. Ten hollow fibers were each cut along a plane passing through the tube axis and immersed in water for 1 hour or more, and then the infrared absorption spectrum was measured. The ratio (Aco) / (Acc) was 0.15.
The number of measurement points below was 0, and the average value μ of the ratio (Aco) / (Acc) was 0.32. As a result of evaluating the amount of adhered platelets, it was 7.2 unit / cm.

【0025】比較例1 実施例1と同様にして得られた中空糸膜を純水中でγ線
照射した。γ線吸収線量は25kGyであった。この中
空糸10本を各々管軸を通る平面で切断して、水に1時
間以上浸漬した後に、赤外吸収スペクトルを測定したと
ころ、比(Aco)/(Acc)が0.15以下の測定点の
数は7で、比(Aco)/(Acc)の平均値μの値は0.
29であった。血小板付着量を評価した結果、53.5
unit/cmであった。
Comparative Example 1 The hollow fiber membrane obtained in the same manner as in Example 1 was irradiated with γ rays in pure water. The absorbed dose of γ rays was 25 kGy. 10 hollow fibers were cut along a plane passing through each tube axis and immersed in water for 1 hour or more, and then the infrared absorption spectrum was measured. The ratio (Aco) / (Acc) was 0.15 or less. The number of points is 7, and the average value μ of the ratio (Aco) / (Acc) is 0.
It was 29. As a result of evaluating the amount of adhered platelets, 53.5
It was unit / cm.

【0026】[0026]

【発明の効果】本発明によれば、抗体、酵素などの分
離、濃縮や血液透析、血液フィルターなどの血液浄化用
膜として、タンパク吸着が抑制されたポリスルホン系膜
を提供することができる。
According to the present invention, it is possible to provide a polysulfone-based membrane in which protein adsorption is suppressed as a membrane for blood purification such as separation and concentration of antibodies and enzymes, hemodialysis and blood filters.

フロントページの続き Fターム(参考) 4C077 AA05 BB01 EE01 EE03 KK11 LL02 LL05 NN04 4D006 GA13 HA01 HA41 LA06 MA01 MA03 MB09 MC36 MC40 MC62 MC62X MC63 MC82 MC88 NA05 NA10 NA13 NA16 NA42 NA75 PA01 PB09 PB53 PC41 PC47 Continued front page    F term (reference) 4C077 AA05 BB01 EE01 EE03 KK11                       LL02 LL05 NN04                 4D006 GA13 HA01 HA41 LA06 MA01                       MA03 MB09 MC36 MC40 MC62                       MC62X MC63 MC82 MC88                       NA05 NA10 NA13 NA16 NA42                       NA75 PA01 PB09 PB53 PC41                       PC47

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】親水性ポリマーまたは親水性セグメントを
含むポリマーを含むポリスルホン系樹脂からなる膜であ
り、赤外吸収スペクトルにおいて20×20μmの視野
角で100点測定したとき、1660cm-1付近のC=O由
来の吸収ピークの強度(Aco)と、1580cm-1付近の
ポリスルホンのベンゼン環C=C由来の吸収ピークの強度
(Acc)の比(Aco)/(Acc)が0.15以下である
測定点の数が5以下であり、比(Aco)/(Acc)の平
均値μが0.1以上0.4未満であることを特徴とする
親水性ポリスルホン系膜。
1. A film comprising a polysulfone-based resin containing a hydrophilic polymer or a polymer containing a hydrophilic segment, which has a C around 1660 cm -1 when measured at 100 points at a viewing angle of 20 × 20 μm in an infrared absorption spectrum. The ratio (Aco) / (Acc) of the intensity (Aco) of the absorption peak derived from ═O and the intensity (Acc) of the absorption peak derived from the benzene ring C = C of polysulfone near 1580 cm −1 is 0.15 or less. A hydrophilic polysulfone-based membrane, wherein the number of measurement points is 5 or less, and the average value μ of the ratio (Aco) / (Acc) is 0.1 or more and less than 0.4.
【請求項2】親水性ポリマーがポリビニルピロリドンで
あることを特徴とする請求項1記載の親水性ポリスルホ
ン系膜。
2. The hydrophilic polysulfone-based membrane according to claim 1, wherein the hydrophilic polymer is polyvinylpyrrolidone.
【請求項3】親水性セグメントがポリビニルピロリドン
であることを特徴とする請求項1記載の親水性ポリスル
ホン系膜。
3. The hydrophilic polysulfone-based membrane according to claim 1, wherein the hydrophilic segment is polyvinylpyrrolidone.
JP2002068050A 2002-03-13 2002-03-13 Hydrophilic polysulfone membrane Expired - Fee Related JP4296746B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002068050A JP4296746B2 (en) 2002-03-13 2002-03-13 Hydrophilic polysulfone membrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002068050A JP4296746B2 (en) 2002-03-13 2002-03-13 Hydrophilic polysulfone membrane

Publications (2)

Publication Number Publication Date
JP2003260340A true JP2003260340A (en) 2003-09-16
JP4296746B2 JP4296746B2 (en) 2009-07-15

Family

ID=28671599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002068050A Expired - Fee Related JP4296746B2 (en) 2002-03-13 2002-03-13 Hydrophilic polysulfone membrane

Country Status (1)

Country Link
JP (1) JP4296746B2 (en)

Also Published As

Publication number Publication date
JP4296746B2 (en) 2009-07-15

Similar Documents

Publication Publication Date Title
JP6036882B2 (en) Separation membrane, separation membrane module, method for producing separation membrane, and method for producing separation membrane module
JP5464127B2 (en) Separation membrane, production method thereof, and separation membrane module using the separation membrane
JP5407713B2 (en) Polysulfone-based hollow fiber membrane module and manufacturing method
JP3474205B2 (en) Polysulfone hollow fiber type blood purification membrane and method for producing the same
JP5338431B2 (en) Polysulfone separation membrane and method for producing polysulfone separation membrane module
KR101157244B1 (en) Process for producing modified substrate and process for modifying separation membrane system
EP1306121B1 (en) Modified hollow-fiber membrane
EP3141296A1 (en) Hollow fiber membrane module and manufacturing method thereof
CN112074340A (en) Porous hollow fiber membrane
JP5633277B2 (en) Separation membrane module
JP6291970B2 (en) Protein adsorbing material, method for producing the same, blood purifier
RU2747972C2 (en) Separation membrane module
JP2012115743A (en) Hollow fiber membrane module
JP4296746B2 (en) Hydrophilic polysulfone membrane
JP2001038170A (en) Hollow fiber membrane
JP2005065711A (en) Absorption material and manufacturing method of the same
JP2003175321A (en) Method for manufacturing hollow fiber membrane
JP5673306B2 (en) Adsorbing material and method for producing adsorbing material
WO2021100804A1 (en) Porous separation membrane
JP4802537B2 (en) Modified substrate
JP2007007643A (en) Production method of reforming separation membrane
JP2003245529A (en) Method for manufacturing hollow fiber membrane
JP2003175322A (en) Method for manufacturing hollow fiber membrane
JPH09299773A (en) Hydropolysulfone film
JP2005231286A (en) Modified substrate

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050222

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080902

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081031

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090324

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090406

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120424

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120424

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130424

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130424

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140424

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees